DOOR (deafness, onychodystrophy, osteodystrophy, mental retardation) syndrome in one of the twins after conception with intracytoplasmic sperm injection

American Journal of Medical Genetics, Part A

Volumn 146, Issue 11, 2008, Pages 1483-1485

  Mihci, Ercan ^a   Guney, Kenan ^a   Velipasaoglu, Sevtap ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGENESIS; CASE REPORT; CHROMOSOME ABERRATION; CONCEPTION; DIZYGOTIC TWINS; EPILEPSY; FEMALE; HEARING IMPAIRMENT; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LETTER; MENTAL DEFICIENCY; NAIL DYSTROPHY; NEUROLOGIC DISEASE; OPHTHALMOLOGY; OSTEODYSTROPHY; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; SPEECH DISORDER; SYNDROME DOOR;

DEAFNESS; FEMALE; FINGER PHALANGES; HUMANS; INFANT; MENTAL RETARDATION; NAILS; SPERM INJECTIONS, INTRACYTOPLASMIC; SYNDROME; TOE PHALANGES; TWINS, DIZYGOTIC;

EID: 44449132177     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32296     Document Type: Letter

References (14)

1. Boundelle M. 2004. Pediatric outcome following infertility management/genetic outcome. International Congress Series 1266:343-350.
2. Cantwell RJ. 1975. Congenital sensorineural deafness associated with onycho-osteo dystrophy and mental retardation (DOOR syndrome). Humangenetik 26:261-265.
3. Eronen M, Somer M, Gustafsson B, Holmberg C. 1985. New syndrome: A digitorenocerebral syndrome. Am J Med Genet 22:281-285.
4. Felix TM, Karam SM, Della Rosa VA, Moraes AMSM. 2002. DOOR syndrome: Report of three additional cases. Clin Dysmorph 11:133-138.
5. Hess RO, Pecotte JK. 1984. Additional case report of the DOOR syndrome. Am J Med Genet 19:401-405.
6. James AW, Miranda SG, Culver K, Hall BD, Golabi M. 2007. DOOR syndrome: Clinical report, literature review and discussion of natural history. Am J Med Genet Part A 143A:2821-2831.
7. Le Merrer M, David A, Goutieres F, Briard ML. 1992. Digito-renocerebral syndrome: Confirmation of Eronen synclrome. Clin Genet 42:196-198.
8. Maher ER. 2005. Imprinting and assisted reproductive technology. Hum Mol Genet 14:R133-R138.
9. Nevin NC, Thomas PS, Calvert J, Rei MMcC. 1982. Deafness, onycho-osteodystrophy, mental retardation (DOOR) syndrome. Am J Med Genet 13:325-332.
10. Patton MA, Krywawych S, Winter RM, Brenton DP, Baraitser M. 1987. DOOR syndrome (deafness, onycho-osteodystrophy, and mental retardation): Elevated plasma and urinary 2-oxoglutarate in three unrelated patients. Am J Med Genet 26: 207-215.
11. Rajab A, Riaz A, Paul G, Al-Khusaibi S, Chalmers R, Patton MA. 2000. Further delineation of the DOOR syndrome. Clin Dysmorphol 9:247-251.
12. Surendran S, Michals-Matalon K, Krywawych S, Qazi QH, Tuchman R, Rady PL, Tyring SK, Matalon R. 2002. DOOR syndrome: Deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex. Am J Med Genet 113:371-374.
13. van Bever Y, Balemans W, Duval EL, Jespers A, Eyskens F, van Hul W, Courtens W. 2007. Exclusion of OGDH and BMP4 as candidate genes in two siblings with autosomal recessive DOOR syndrome. Am J Med Genet Part A 143A:763-767.
14. Winter RM. 1993. Eronen syndrome identical with DOOR syndrome? Clin Genet 43:167.